FDA grants orphan designation to Airway Therapeutics

Story excerpt provided by Cincinnati Enquirer.

Written by Josh Pichler.

U.S. regulators have granted orphan designation to Airway Therapeutics, the local startup working to help extremely premature babies avoid developing a serious condition called bronchopulmonary dysplasia (BPD).

The designation is another boost for the startup that spun out of Cincinnati Children’s Hospital Medical Center, and that became operational in 2011. Cincinnati Children’s, along with CincyTech, is an investor.

Click here to read the complete article.

Originally published June 26, 2014.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: